Asia Pacific Ophthalmic Drugs Market By Disease Indication (Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, Allergy, Uveitis, And Others), By Therapeutic Class (Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-allergy Drugs, Anti-VEGF Agents, Others), By Product Type (Prescription Drugs, Over-the-Counter Drugs), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Independent Pharmacies & Drug Stores), By Dosage Form (Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems, Other Ophthalmic Drug Forms), By Technology (Biologics, Cell Therapy, Gene Therapy, Drug Delivery, Small Molecule, Others), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

Asia Pacific Ophthalmic Drugs Market By Disease Indication (Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, Allergy, Uveitis, And Others), By Therapeutic Class (Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-allergy Drugs, Anti-VEGF Agents, Others), By Product Type (Prescription Drugs, Over-the-Counter Drugs), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Independent Pharmacies & Drug Stores), By Dosage Form (Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems, Other Ophthalmic Drug Forms), By Technology (Biologics, Cell Therapy, Gene Therapy, Drug Delivery, Small Molecule, Others), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

ID: 5491 | Pages: 145 | December 2017 | Region: Asia Pacific


The Asia Pacific Ophthalmic Drugs market size was around USD 6 billion in 2017. It is expected to grow at a CAGR of 6.9% to reach USD 8.38 billion by 2022. It captures 20% of the global market share.

Ophthalmic drugs are used for the treatment of various eye disorders like cataract, glaucoma etc.

Increasing number of people suffering from glaucoma all over the world, high innovation in and heavy funding in the development of combination therapies are the major factors driving the growth of this market.

Adverse side-effects and long gestation periods in the development of new drugs are the factors hampering market growth.

The market is segmented by therapeutic class, product type, disease indication, distribution channel, dosage form and technology. Classification by disease indication entails Allergy, Dry Eye, Retinal Disorders, Glaucoma, Infection/Inflammation, Uveitis, and others. Retinal disorders captured largest market share however glaucoma is anticipated to grow with the highest CAGR in the forecast period. Classification by therapeutic class entails Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-allergy Drugs, Anti-VEGF Agents, and others. Classification by product type entails Over-the-Counter Drugs and Prescription Drugs. Classification by distribution channel entails Hospital Pharmacies, Independent Pharmacies & Drug Stores and Online Pharmacies. Classification by dosage form entails Solid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems, Semisolid Ophthalmic Drug Forms, Liquid Ophthalmic Drug Forms, and Other Ophthalmic Drug Forms. Liquid Ophthalmic drug market sub-category is expected to retain its lead in the market in the forecast period as it is predicted to grow with the highest CAGR in the forecast period. Classification by technology entails Biologics, Cell Therapy, Gene Therapy, Drug Delivery, Small molecule, and others.

Classification by geography entails India, China, Korea, Japan and others. Asia Pacific is the fastest growing market and will continue its growth streak till the end of 2022.

Key players in the market are Carl-Zeiss AG, Ellex Medical Lasers Ltd., Hoya Corporation, Novagali Pharma S A, Abbott Medical Optics, Inc., Essilor International S.A. Other players in the market include Insight Vision Inc., Nidek Co.Ltd, Topcon Corporation, and Ziemer Ophthalmic Systems AG.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Therapeutic Class                     

                                5.1.1 Introduction           

                                5.1.2 Anti-inflammatory Drugs  

                                                5.1.2.1 Nonsteroidal Anti-inflammatory Drugs

                                                5.1.2.2 Steroids

                                5.1.3 Anti-infective Drugs            

                                                5.1.3.1 Anti-fungal Drugs

                                                5.1.3.2 Anti-bacterial Drugs

                                                5.1.3.3 Others

                                5.1.4 Anti-glaucoma Drugs          

                                                5.1.4.1 Alpha Agonist

                                                5.1.4.2 Beta Blockers

                                                5.1.4.3 Prostaglandin Analogs

                                                5.1.4.4 Combined Medication

                                                5.1.4.5 Others

                                5.1.5 Anti-allergy Drugs

                                5.1.6 Anti-VEGF Agents

                                5.1.7 Others      

                                5.1.8 Y-o-Y Growth Analysis, By Therapeutic Class            

                                5.1.9 Market Attractiveness Analysis, By Therapeutic Class          

                                5.1.10 Market Share Analysis, By Therapeutic Class         

                5.2 Product Type                             

                                5.2.1 Introduction           

                                5.2.2 Prescription Drugs               

                                5.2.3 Over-the-Counter Drugs   

                                5.2.4 Y-o-Y Growth Analysis, By Product Type    

                                5.2.5 Market Attractiveness Analysis, By Product Type  

                                5.2.6 Market Share Analysis, By Product Type    

                5.3 Distribution Channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospital Pharmacies            

                                5.3.3 Online  Pharmacies              

                                5.3.4 Independent Pharmacies & Drug Stores    

                                5.3.5 Y-o-Y Growth Analysis, By Distribution Channel      

                                5.3.6 Market Attractiveness Analysis, By Distribution Channel    

                                5.3.7  Market Share Analysis, By Distribution Channel     

                5.4 Disease Indications                 

                                5.4.1 Introduction           

                                5.4.2 Dry Eye     

                                5.4.3 Glaucoma

                                5.4.4 Infection/Inflammation     

                                5.4.5 Retinal Disorders  

                                                5.4.5.1 Wet Age-related Macular Degeneration

                                                5.4.5.2 Dry Age-related Macular Degeneration

                                                5.4.5.3 Diabetic Retinopathy

                                                5.4.5.4 Others

                                5.4.6 Allergy      

                                5.4.7 Uveitis      

                                5.4.8 Others      

                                5.4.9 Y-o-Y Growth Analysis, By Disease Indications         

                                5.4.10 Market Attractiveness Analysis, By Disease Indications    

                                5.4.11 Market Share Analysis, By Disease Indications      

                5.5 Dosage Form                             

                                5.5.1 Introduction           

                                5.5.2 Liquid Ophthalmic Drug Forms        

                                5.5.3 Solid Ophthalmic Drug Forms          

                                5.5.4 Semisolid Ophthalmic Drug Forms

                                5.5.5 Multicompartment Drug Delivery Systems               

                                5.5.6 Other Ophthalmic Drug Forms        

                                5.5.7 Y-o-Y Growth Analysis, By Dosage Form     

                                5.5.8  Market Attractiveness Analysis, By Dosage Form  

                                5.5.9  Market Share Analysis, By Dosage Form   

                5.6 Technology                 

                                5.6.1 Introduction           

                                5.6.2 Biologics   

                                5.6.3 Cell Therapy           

                                5.6.4 Gene Therapy       

                                5.6.5 Drug Delivery         

                                5.6.6 Small molecule      

                                5.6.7 Others      

                                5.6.8 Y-o-Y Growth Analysis, By Technology        

                                5.6.9 Market Attractiveness Analysis, By Technology      

                                5.6.10 Market Share Analysis, By Technology     

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Therapeutic Class

                                                6.1.3.3 By Product Type

                                                6.1.3.4 By Distribution Channel

                                                6.1.3.5 By Disease Indication

                                                6.1.3.6 By Dosage Form

                                                6.1.3.7 By Technology

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Therapeutic Class

                                                6.1.4.3 By Product Type

                                                6.1.4.4 By Distribution Channel

                                                6.1.4.5 By Disease Indication

                                                6.1.4.6 By Dosage Form

                                                6.1.4.7 By Technology

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Therapeutic Class

                                                6.1.5.3 By Product Type

                                                6.1.5.4 By Distribution Channel

                                                6.1.5.5 By Disease Indication

                                                6.1.5.6 By Dosage Form

                                                6.1.5.7 By Technology

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Medical Optics, Inc.                 

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Carl-Zeiss AG                             

                8.3 Ellex Medical Lasers Ltd.                       

                8.4 Essilor International S.A.                       

                8.5 Hoya Corporation                    

                8.6 Insight Vision Inc.                     

                8.7 Nidek Co.Ltd                              

                8.8 Novagali Pharma S A                               

                8.9 Topcon Corporation                                

                8.10 Ziemer Ophthalmic Systems AG.                    

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type and Packaged Containers along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Ophthalmic Drugs  Market By Disease Indication, From 2016-2022 ( USD Billion )
  2. Asia Pacific Dry Eye Market By Region, From 2016-2022 ( USD Billion )
  3. Asia Pacific Glaucoma Market By Region, From 2016-2022 ( USD Billion )
  4. Asia Pacific Infection/Inflammation Market By Region, From 2016-2022 ( USD Billion )
  5. Asia Pacific Retinal Disorders Market By Region, From 2016-2022 ( USD Billion )
  6. Asia Pacific Allergy Market By Region, From 2016-2022 ( USD Billion )
  7. Asia Pacific Uveitis Market By Region, From 2016-2022 ( USD Billion )
  8. Asia Pacific Others Market By Region, From 2016-2022 ( USD Billion )
  9. Asia Pacific Ophthalmic Drugs  Market By Therapeutic Class, From 2016-2022 ( USD Billion )
  10. Asia Pacific Anti-inflammatory Drugs Market By Region, From 2016-2022 ( USD Billion )
  11. Asia Pacific Anti-infective Drugs Market By Region, From 2016-2022 ( USD Billion )
  12. Asia Pacific Anti-glaucoma Drugs Market By Region, From 2016-2022 ( USD Billion )
  13. Asia Pacific Anti-allergy Drugs Market By Region, From 2016-2022 ( USD Billion )
  14. Asia Pacific Anti-VEGF Agents Market By Region, From 2016-2022 ( USD Billion )
  15. Asia Pacific Others Market By Region, From 2016-2022 ( USD Billion )
  16. Asia Pacific Ophthalmic Drugs  Market By Product Type, From 2016-2022 ( USD Billion )
  17. Asia Pacific Prescription Drugs Market By Region, From 2016-2022 ( USD Billion )
  18. Asia Pacific Over-the-Counter Drugs Market By Region, From 2016-2022 ( USD Billion )
  19. Asia Pacific Ophthalmic Drugs  Market By Distribution Channel, From 2016-2022 ( USD Billion )
  20. Asia Pacific Hospital Pharmacies Market By Region, From 2016-2022 ( USD Billion )
  21. Asia Pacific Online Pharmacies Market By Region, From 2016-2022 ( USD Billion )
  22. Asia Pacific Independent Pharmacies & Drug Stores Market By Region, From 2016-2022 ( USD Billion )
  23. Asia Pacific Ophthalmic Drugs  Market By Dosage Form, From 2016-2022 ( USD Billion )
  24. Asia Pacific Liquid Ophthalmic Drug Forms Market By Region, From 2016-2022 ( USD Billion )
  25. Asia Pacific Solid Ophthalmic Drug Forms Market By Region, From 2016-2022 ( USD Billion )
  26. Asia Pacific Semisolid Ophthalmic Drug Forms Market By Region, From 2016-2022 ( USD Billion )
  27. Asia Pacific Multicompartment Drug Delivery Systems Market By Region, From 2016-2022 ( USD Billion )
  28. Asia Pacific Other Ophthalmic Drug Forms Market By Region, From 2016-2022 ( USD Billion )
  29. Asia Pacific Ophthalmic Drugs  Market By Technology, From 2016-2022 ( USD Billion )
  30. Asia Pacific Biologics Market By Region, From 2016-2022 ( USD Billion )
  31. Asia Pacific Cell Therapy Market By Region, From 2016-2022 ( USD Billion )
  32. Asia Pacific Gene Therapy Market By Region, From 2016-2022 ( USD Billion )
  33. Asia Pacific Drug Delivery Market By Region, From 2016-2022 ( USD Billion )
  34. Asia Pacific Small molecule Market By Region, From 2016-2022 ( USD Billion )
  35. Asia Pacific Others Market By Region, From 2016-2022 ( USD Billion )
  36. Japan Ophthalmic Drugs  Market By Disease Indication, From 2016-2022 ( USD Billion )
  37. Japan Ophthalmic Drugs  Market By Therapeutic Class, From 2016-2022 ( USD Billion )
  38. Japan Ophthalmic Drugs  Market By Product Type, From 2016-2022 ( USD Billion )
  39. Japan Ophthalmic Drugs  Market By Distribution Channel, From 2016-2022 ( USD Billion )
  40. Japan Ophthalmic Drugs  Market By Dosage Form, From 2016-2022 ( USD Billion )
  41. Japan Ophthalmic Drugs  Market By Technology, From 2016-2022 ( USD Billion )
  42. China Ophthalmic Drugs  Market By Disease Indication, From 2016-2022 ( USD Billion )
  43. China Ophthalmic Drugs  Market By Therapeutic Class, From 2016-2022 ( USD Billion )
  44. China Ophthalmic Drugs  Market By Product Type, From 2016-2022 ( USD Billion )
  45. China Ophthalmic Drugs  Market By Distribution Channel, From 2016-2022 ( USD Billion )
  46. China Ophthalmic Drugs  Market By Dosage Form, From 2016-2022 ( USD Billion )
  47. China Ophthalmic Drugs  Market By Technology, From 2016-2022 ( USD Billion )
  48. India Ophthalmic Drugs  Market By Disease Indication, From 2016-2022 ( USD Billion )
  49. India Ophthalmic Drugs  Market By Therapeutic Class, From 2016-2022 ( USD Billion )
  50. India Ophthalmic Drugs  Market By Product Type, From 2016-2022 ( USD Billion )
  51. India Ophthalmic Drugs  Market By Distribution Channel, From 2016-2022 ( USD Billion )
  52. India Ophthalmic Drugs  Market By Dosage Form, From 2016-2022 ( USD Billion )
  53. India Ophthalmic Drugs  Market By Technology, From 2016-2022 ( USD Billion )
  54. Australia Ophthalmic Drugs  Market By Disease Indication, From 2016-2022 ( USD Billion )
  55. Australia Ophthalmic Drugs  Market By Therapeutic Class, From 2016-2022 ( USD Billion )
  56. Australia Ophthalmic Drugs  Market By Product Type, From 2016-2022 ( USD Billion )
  57. Australia Ophthalmic Drugs  Market By Distribution Channel, From 2016-2022 ( USD Billion )
  58. Australia Ophthalmic Drugs  Market By Dosage Form, From 2016-2022 ( USD Billion )
  59. Australia Ophthalmic Drugs  Market By Technology, From 2016-2022 ( USD Billion )
  60. South Korea Ophthalmic Drugs  Market By Disease Indication, From 2016-2022 ( USD Billion )
  61. South Korea Ophthalmic Drugs  Market By Therapeutic Class, From 2016-2022 ( USD Billion )
  62. South Korea Ophthalmic Drugs  Market By Product Type, From 2016-2022 ( USD Billion )
  63. South Korea Ophthalmic Drugs  Market By Distribution Channel, From 2016-2022 ( USD Billion )
  64. South Korea Ophthalmic Drugs  Market By Dosage Form, From 2016-2022 ( USD Billion )
  65. South Korea Ophthalmic Drugs  Market By Technology, From 2016-2022 ( USD Billion )
Middle-East And Africa Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Resea...
Latin America Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Insti...
Asia-Pacific Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Instit...
Europe Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Institutes, ...
North America Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Insti...
ANtibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Institutes, Hospita...
Middle-East And Africa Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity As...
Latin America Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tis...
Asia-Pacific Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tiss...
Europe Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tissues Cu...
North America Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tis...
Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tissues Culture A...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.